Dr. Melody Stone

Claim this profile

MediSearch Clinical Trials

Studies Atopic Dermatitis
Studies Eczema
5 reported clinical trials
4 drugs studied

Affiliated Hospitals

Image of trial facility.
MediSearch Clinical Trials

Clinical Trials Melody Stone is currently running

More about Melody Stone

Clinical Trial Related1 year of experience running clinical trials · Led 5 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Melody Stone has experience with
  • Lebrikizumab
  • Placebo
  • Baricitinib
  • Daxdilimab

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Melody Stone specialize in?
Melody Stone focuses on Atopic Dermatitis and Eczema. In particular, much of their work with Atopic Dermatitis has involved treating patients, or patients who are undergoing treatment.
Is Melody Stone currently recruiting for clinical trials?
Yes, Melody Stone is currently recruiting for 2 clinical trials in Saint Joseph Missouri. If you're interested in participating, you should apply.
Are there any treatments that Melody Stone has studied deeply?
Yes, Melody Stone has studied treatments such as Lebrikizumab, Placebo, Baricitinib.
What is the best way to schedule an appointment with Melody Stone?
Apply for one of the trials that Melody Stone is conducting.
What is the office address of Melody Stone?
The office of Melody Stone is located at: MediSearch Clinical Trials, Saint Joseph, Missouri 64506 United States. This is the address for their practice at the MediSearch Clinical Trials.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.